CSIMarket Company Name, Ticker, Competitors, else..
 

Spectrum Pharmaceuticals Inc   (NASDAQ: SPPI)

Spectrum Pharmaceuticals Inc 's

Competitiveness



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 

SPPI Sales vs. its Competitors Q1 2023


Comparing the current results to its competitors, Spectrum Pharmaceuticals Inc reported Revenue increase in the 1 quarter 2023 by 0 % year on year.
The revenue growth was below Spectrum Pharmaceuticals Inc 's competitors' average revenue growth of 23.57 %, achieved in the same quarter.

• List of SPPI Competitors





Revenue Growth Comparisons




Net Income Comparison

Spectrum Pharmaceuticals Inc , slower than the average decrease reported by the company's competitors of -36.53 %. recorded a net loss and most of the company's competitors saw a decline in earnings by -36.53 %

<<  SPPI Stock Performance Comparisons





*Market share is calculated based on total revenue.





Publicly Traded Peers of Spectrum Pharmaceuticals Inc




Iterum Therapeutics Plc
Share Performance



-92.06%
One Year
Iterum Therapeutics Plc
Profile

Iterum Therapeutics Plc is a pharmaceutical company that focuses on the research, development, and commercialization of innovative anti-infectives for the treatment of serious and life-threatening infections. They aim to address unmet medical needs in this space by advancing their product candidates through clinical trials and ultimately bringing them to market.

More about Iterum Therapeutics Plc's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 3.435 mill. $ - mill. $ -26.961 mill.


Nascent Biotech Inc
Share Performance



0.00%
Over The Past 5 Days
Nascent Biotech Inc
Profile

Nascent Biotech Inc's business model is focused on the development and commercialization of innovative therapies in the field of biotechnology. They aim to leverage their expertise and research to bring new drugs to market that can address critical unmet medical needs.

More about Nascent Biotech Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 0.051 mill. $ - mill. $ -1.925 mill.


Novan Inc
Share Performance



-77.60%
30 Days
Novan Inc
Profile

Novan Inc is a biotechnology company that operates on a dermatology-focused business model. They develop and commercialize innovative therapies that address unmet medical needs in dermatology by utilizing their proprietary nitric oxide technology platform. Novan Inc primarily focuses on developing topical treatments for a range of skin conditions such as acne, atopic dermatitis, and fungal infections.

More about Novan Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 2.458 mill. $ 24.920 mill. $ -32.050 mill.


Novartis Ag
Share Performance



+27.32%
One Year
Novartis Ag
Profile

Novartis AG's business model is centered around the development, manufacturing, and marketing of innovative pharmaceutical products.

More about Novartis Ag's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 315,214.425 mill. $ 56,674.000 mill. $ 17,991.000 mill.


Nexien Biopharma Inc
Share Performance



0.00%
Over The Past 5 Days
Nexien Biopharma Inc
Profile

Nexien Biopharma Inc operates as a biotechnology company focused on the development and commercialization of innovative therapies for various medical conditions. They aim to use their expertise in biopharmaceutical research to bring novel treatments to market, improving patient outcomes and meeting unmet medical needs.

More about Nexien Biopharma Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 0.007 mill. $ - mill. $ -0.188 mill.

88 more competitors available

Sign in to see all competitors

Sign In Create Free Account

Sources: Spectrum Pharmaceuticals Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Spectrum Pharmaceuticals Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.